News/Recently@Retina

Recently@Retina Newsletter July 2023

July 25, 2023

Recently@Retina

July 2023

The mission of the Retina Foundation of the Southwest is to prevent vision loss and restore sight through innovative research and treatment for pediatric eye conditions, inherited eye diseases, and age-related macular degeneration.

— LATEST NEWS & EVENTS —

 

July 2023 Recently At Retina Newsletter Img 1

What is a

child’s most

important school

supply?

 

Their Eyes!

Two to three children in every classroom have amblyopia (lazy eye), but until recently the only treatment was to cover the child’s stronger eye with a patch. While the stronger eye is covered, the child’s weaker eye can strengthen its connection to the brain. Understandably children do not enjoy patching, so Retina Foundation scientist Dr. Eileen Birch is investigating alternative treatments for amblyopia, the most common cause of vision loss in children.

Children in the most recent study are provided an iPad fitted with a polarizing screen overlay. Instead of the hated eye patch, the child will wear polarizing glasses that block the stronger eye’s view of the iPad screen. Taking this mobile treatment with them, the child can do anything they want on the iPad – play games, do homework, or watch videos – during treatment.

To monitor home treatment time, a small sensor in a 3-D printed “sensor holder” designed and donated by local company, Midi Maker is slid onto the glasses. With enough treatment time, the connections between the weaker eye and the brain are strengthened and vision improves. We think that this patch-free treatment will lead to better compliance and better vision outcomes than patching.

ClinicalTrials.gov, NCT05440448, Patch-free Occlusion

 

July 2023 Recently At Retina Newsletter Img 2

iPad and glasses customized with polarized screen overlay/lenses

July 2023 Recently At Retina Newsletter Img 3

Customized glasses with compliance sensor attached

July 2023 Recently At Retina Newsletter Img 4

Sensor in 3-D printed holder created and donated by Midi Maker

July 2023 Recently At Retina Newsletter Img 5

Inserting the sensor into the hub uploads the recorded compliance time

July 2023 Recently At Retina Newsletter Img 6

Mark

Your

Calendars:

September 21st

Spread the word!

Spread the word to your friends and loved ones about the

Retina Foundation and NTX Giving Day!

Don’t forget to tag #RetinaFoundation #NTxGivingDay and

#FindYourPassionGiveWithPurpose if you’re posting online!

Encourage your friends and family to get up and give as well!

Follow us!

Follow us at facebook.com/NorthTexasGivingDay to stay up to date!

Communities Foundation of Texas is even offering a prize for the social media post that’s shared the most!

 

August 2023 Recently At Retina Newsletter Img 10

Recent

Clinical Trials

@Retina

 

July 2023 Recently At Retina Newsletter Img 8Finding the Best Dose of a New Drug for Retinal Dystrophy

Rose-Silverthorne Laboratory

ClinicalTrials.gov ID: NCT05902962

Single Arm Dose Escalation Study to Evaluate the Safety and Tolerability of IVT VP-001 in Patients with PRPF31- Associated Retinitis Pigmentosa (RP)

Will an Investigational Drug Alter Course of Late-Stage Dry AMD?

July 2023 Recently At Retina Newsletter Img 9

Molecular Ophthalmology Laboratory

ClinicalTrials.gov ID: NCT05811351

A Study to Evaluate Intravitreal JNJ- 81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Comparing the Accuracy of Two New Vision Screening DevicesJuly 2023 Recently At Retina Newsletter Img 10

Crystal Charity Ball Pediatric Vision Laboratory

ClinicalTrials.gov ID: NCT03919708

Deploying Retinal Birefringence Imaging into the Clinic for Pediatric Vision Screening

 

 

Please help the Retina Foundation continue

leading research and saving sight.

 

Recently@Retina Newsletter July 2023

Related Articles

Recently@Retina Newsletter August 2024 Promising Results From Ongoing Phase 1/2 Clinical Trial for X-Linked Retinitis Pigmentosa (XLRP) Measuring the Release of A Therapeutic Drug in a Controlled Lab Setting Recently@Retina Newsletter August 2023 Exclusive: Retina Foundation Receives $1 Million Donation to Advance Ocular Stem Cell Lab
Mailicon
Get the Latest Updates

Sign up to receive emails from Retina Foundation that will keep you up-to-date on our research and events.

  • This field is for validation purposes and should be left unchanged.
Contact Us

Contact Us

  • This field is for validation purposes and should be left unchanged.
x

Please check all that apply:

How did you learn about the
Retina Foundation?

  • Please check all that apply:
  • This field is for validation purposes and should be left unchanged.
Contact Us

Request an Appointment

Please complete this form if you are interested in speaking to a member of our team about your AMD.

all fields required

DOWNLOAD Printable Form